The invention provides engineered
Escherichia coli and application thereof, and relates to the technical field of
biology, natural I-type fimbriae are knocked out of the engineered
Escherichia coli, and the non-specific targeting adhesion rate of the engineered
Escherichia coli can be effectively reduced under the conditions that the growth condition of the engineered
Escherichia coli is not changed and the shape of the engineered
Escherichia coli is too small; by replacing
engineering bacteria to artificially synthesize an
extracellular single-domain
antibody sequence of adhesin (intimin or YeeJ), flexible targeting of various target cells is realized, and the
antibody has the potential to become a precise treatment kit. And the method is convenient and time-saving, and provides a powerful tool for the evaluation of the affinity of the
antibody in the
antibody screening work. The
engineering bacterium provided by the invention can be specifically colonized in tumors, has a certain
tumor growth inhibition effect, and has relatively high
biological safety. Furthermore, cytotoxic molecules are added on the basis of targeted adhesion, so that the induction of
tumor cell apoptosis can be accelerated, and a remarkable anti-
cancer effect is achieved.